Serve as the U.S. Partner within the global STOP TB Partnership and participate in STOP TB Partnership activities | Apply Online

Frequently Asked Questions (FAQs)

What is the main purpose of this funding opportunity?

This cooperative agreement supports U.S. participation in the global STOP TB Partnership. The recipient is expected to serve as the U.S. partner within the Partnership and actively participate in STOP TB Partnership activities that advance international tuberculosis (TB) prevention, control, and elimination efforts.

Is this a new program or continuation funding?

This is a continuation cooperative agreement. The emphasis is on maintaining and supporting ongoing engagement, coordination, and collaboration with the STOP TB Partnership and its members, rather than launching a brand-new standalone program.

Which agency is offering this opportunity?

The opportunity is offered by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC).

What is the funding opportunity number and title?

The opportunity is identified as CDC RFA PS12-120805CONT16. The title is "Serve as the U.S. Partner within the global STOP TB Partnership and participate in STOP TB Partnership activities."

What type of funding instrument is being used?

The funding instrument is a cooperative agreement. This typically means CDC will have substantial involvement in the supported activities, such as regular coordination, shared planning, and reporting expectations.

What does "cooperative agreement" imply about CDC involvement?

Because this is a cooperative agreement, CDC involvement is expected to be more active than in a standard grant. The supported work is described as involving ongoing coordination and collaboration, which commonly includes routine engagement with CDC and oversight aligned to the cooperative nature of the award.

What is the activity category for this opportunity?

The activity category is health.

What CFDA number is associated with this opportunity?

The opportunity is listed under CFDA 93.947, which corresponds to CDC global health-related programming.

Who is eligible to apply?

Eligibility is listed broadly as "Others," with a note indicating applicants should consult the additional eligibility text in the full announcement for clarification. Given that this is a continuation opportunity, eligibility may be limited to organizations that meet specific criteria (for example, prior recipients or entities with a defined role or specialized capacity), but the specific eligibility conditions are referenced as being in the full announcement.

What is the application deadline?

The listing shows a single closing date of April 29, 2016 (both original and current).

When was the opportunity posted?

The notice indicates it was created and posted on March 1, 2016.

How long was the application window?

Based on the posting date (March 1, 2016) and closing date (April 29, 2016), the application window appears relatively short, which is often consistent with continuation funding actions.

What is the award ceiling (maximum funding amount)?

The listing shows an award ceiling of 0. This commonly means the maximum award amount is not specified in the public synopsis, may depend on available appropriations, or may be defined elsewhere in the full funding announcement and related budget guidance.

How many awards are expected?

The expected number of awards is stated as 50.

What does it mean that 50 awards are expected for a continuation opportunity?

An expected number of 50 awards can indicate that CDC anticipated multiple continuation actions under a broader program umbrella, or multiple funded components tied to STOP TB Partnership participation, rather than a single standalone award.

What kinds of activities are supported under this opportunity?

The supported work is described as ongoing engagement, coordination, and collaboration with the STOP TB Partnership and its members. This may include participating in partnership meetings, working groups, strategic coordination, governance engagement, technical work, and collaborative initiatives connected to global TB prevention, control, and elimination efforts.

What is the recipient expected to do within the STOP TB Partnership?

The recipient is expected to serve as the U.S. partner and take an active role in Partnership activities. This centers on representation and participation that advances international TB-related goals through the global STOP TB Partnership framework.

Is this opportunity focused on domestic TB programs or international efforts?

The stated focus is international TB prevention, control, and elimination efforts through U.S. participation in the global STOP TB Partnership.

Does this opportunity emphasize direct service delivery or partnership coordination?

The description emphasizes ongoing engagement, coordination, and collaboration with the Partnership and its members, reflecting a role centered on participation and coordination rather than establishing a new standalone direct-service program.

Where can applicants find the detailed eligibility and budget guidance?

The listing indicates that additional eligibility clarification is provided in the full announcement. The award ceiling is also not specified in the synopsis, implying more detailed funding and budget information may be contained in the full funding announcement and its budget guidance.